pennystockhaven
  • Facebook
  • Google
  • Pinterest
  • Twitter
  • Youtube
  • Rss
Day-Trading Penny Stocks
  • Home
  • Services
  • Contact Us
Home» Commentary (Page 3)

AntriaBio (ANTB): An Opportunity

Posted on March 17, 2013 by PennyStockHaven in Commentary

“Must-Read” review from BiotechIntel Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. Over $100,000,000 has been invested in developing this super-drug that threatens to make […]

Read More

AntriaBio (ANTB): Bounce Opportunity

Posted on March 14, 2013 by PennyStockHaven in Commentary, Stock Picks

Antriabio – which trades under the ticker “ANTB” – is about to bounce. If you’ve been following what I have to say I also think ANTB has 10-bagger potential (more about that in a moment). According to otcshortreport.com, about 50% of the shares that have traded in the last 30 days were sold short. A […]

Read More

Day-Trading ARCA Biopharma (ABIO)

Posted on January 30, 2013 by PennyStockHaven in Commentary, Market Movers & Losers, Stock Picks

ARCA Biopharma (ABIO) has been alerted as day-trading investment opportunity in real-time to our Twitter & Facebook followers at an around $.50/share. ABIO stock closed at $.68/share for the solid  36% in day-trading gains. Yesterday ABIO announced an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro […]

Read More

Mid-Term Investment Opportunity with AntriaBio (ANTB)

Posted on January 22, 2013 by PennyStockHaven in Commentary, Stock Picks

edited on 02/02/2013: AntriaBio, Inc. (“AntriaBio”) announced that FINRA has approved a change of the Company’s stock ticker symbol. Effective today, the Company’s common shares will commence trading on the OTC Bulletin Board under the trading symbol “ANTB” ( OTCQB : ANTB ). The previous trading symbol was “FMYY” ( OTCQB : FMYY ). AntriaBio, […]

Read More

IBIO, UPIP, TELK: Plays On Biotech And Technology Markets

Posted on January 13, 2013 by PennyStockHaven in Commentary, Stock Market Movers & Losers

Sophisticated traders must take a look at iBio, Inc. (IBIO) as it seems that company has been overlooked as a solid player on the flu market. The high level of flu cases being reported across all states in the USA and Europe. Only in New York state a flu epidemic has hit more than 19,000 […]

Read More

Trading Opportunity with Zoom Technologies (ZOOM)

Posted on January 7, 2013 by PennyStockHaven in Commentary, Stock Market News, Stock Picks

Zoom Technologies (ZOOM) has been alerted on Twitter, as a trading opportunity, after company’s announcement of the execution of a definitive agreement pursuant to which it will sell its China-based manufacturing, sales and marketing, and R&D subsidiaries, and that the proceeds of the sale will be used for the purchase of additional U.S.-based businesses. Zoom […]

Read More

Trading Idea with Catalyst Pharmaceutical Partners (NASDAQ:CPRX)

Posted on January 6, 2013 by PennyStockHaven in Commentary, Stock Picks

Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock found a bottom after  sell-off (tax-losses) in the mid-December 2012 and now offers a solid trading opportunity. Besides technical analysis, there are more reasons to join this trade: CPRX announced on December 27th that it received a Nasdaq Staff Deficiency Letter for not compliance with the Minimum Bid Price requirement ($1/share) […]

Read More

Eagle Bulk Shipping (EGLE) & Excel Maritime Carriers (EXM): Day-Trading Gains

Posted on January 4, 2013 by PennyStockHaven in Commentary, Stock Market Movers & Losers

Shipping Industry was one of the hottest stock market segments today. Some of the market analysts believe that the spike in share prices is a response to the Baltic Dry Index (BDI), which is going into a positive territory since been trampled at the 2012. Anyhow, looks like bottom has been formed in the one […]

Read More

Amicus Therapeutics (FOLD): Positive Results in Phase 2 Chaperone-Enzyme Replacement Therapy (ERT)

Posted on January 4, 2013 by PennyStockHaven in Commentary, Market Movers & Losers, Stock Market News

Amicus Therapeutics (FOLD) has been profiled as a bounce play from December 31th, 2012. Since then FOLD shares gained over 50% (as of now) and have continued their march to the new highs. Today Amicus Therapeutics announced positive preliminary results from all 4 dose cohorts in a Phase 2 study (Study 010) to evaluate the […]

Read More

AEZS, CTIX, FOLD: Biotech’s Buzz on the Street

Posted on December 30, 2012 by PennyStockHaven in BUZZ on the Street, Commentary

Aeterna Zentaris Inc. (AEZS) On December 28th Aeterna Zentaris announced that it has reached an agreement with the U.S. Food and Drug Administration (“FDA”) on a Special Protocol Assessment (“SPA”) for an upcoming Phase 3 registration trial in endometrial cancer with its doxorubicin peptide conjugate, AEZS-108. Optimistic market reaction on this announcement boosted AEZS shares […]

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »

Search

Navigate

  • Home
  • Services
  • Contact Us
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Publishers

Updates

  • ReWalk Robotics (RWLK): Yesterday, Today and Tomorrow June 8, 2019
  • Amyris, Inc. (AMRS): How to Mislead Investors April 21, 2019
  • ADMA Biologics, Inc. (ADMA): Offering is Imminent April 11, 2019
  • Proteostasis Therapeutics (PTI): Market Overreaction March 26, 2019
  • Dynagas LNG Partners LP (NYSE: DLNG) Coming Off Of Bottom February 1, 2019
  • Histogenics Corporation (HSGX) market: only upside from these levels September 5, 2018

Site

  • Home
  • Services
  • Contact Us
  • About Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Publishers

Stocks

  • Financial Network
  • Free Investment Newsletter
  • Penny Stocks
  • Public Relations and Subscription Services
eBay sniper

Financial Network

Yahoo Finance
Reuters
The Motley Fool
WSJ
CNBC
Business Week
The Street
Bloomberg

psh sloganYour Everything Penny Stocks Resource



Copyright © 2018 PennyStockHaven.com. All Rights Reserved